BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis.
Shigeyasu K, Yamamoto H, Takahashi T, Moriwake K, Kayano M, Takeda S, Matsumi Y, Umeda Y, Kondo Y, Teraishi F, Yasui K, Fuji T, Kagawa S, Fujiwara T.
Shigeyasu K, et al. Among authors: fujiwara t.
Int Cancer Conf J. 2024 Apr 18;13(3):189-192. doi: 10.1007/s13691-024-00678-2. eCollection 2024 Jul.
Int Cancer Conf J. 2024.
PMID: 38962037
Free PMC article.